The National Institute of Diabetes and Digestive and Kidney Diseases requires synthesis scale-up, custom synthesis, purification, and characterization of specialized sulfanylbenzamide and cyclopentane peptide nucleic acid compounds for cancer and HIV research. These materials are not commercially available and are needed for preclinical evaluation and lead candidate optimization. No specific timelines, budget amounts, or location for performance of services are mentioned in the description.